Related Experiment Video
Updated: Apr 20, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing
Insights
Undiagnosed abnormal glucose regulation is highly prevalent in patients undergoing coronary angiography. Glycated hemoglobin (HbA1c) shows strong performance for screening, potentially serving as an alternative to oral glucose tolerance tests (OGTT).
Area of Science:
- Cardiology
- Endocrinology
- Clinical Diagnostics
Background:
- Coronary angiography (CAG) patients often have undiagnosed abnormal glucose regulation (AGR), including diabetes and prediabetes.
- Screening for AGR is crucial for cardiovascular risk management.
- Current screening methods have limitations in this patient population.
Purpose of the Study:
- To determine the prevalence of undiagnosed AGR in patients undergoing CAG.
- To compare the effectiveness of glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), and 2-hour plasma glucose (2hPG) in screening for AGR.
- To evaluate HbA1c and oral glucose tolerance test (OGTT) as combined screening tools.
Main Methods:
- Adult patients without known diabetes undergoing CAG were enrolled.
- Glucose regulation status was assessed using HbA1c and OGTT post-discharge.
- Receiver operating characteristic (ROC) analysis evaluated the performance of FPG, 2hPG, and HbA1c for AGR detection.
Main Results:
- The study included 689 subjects.
- AGR prevalence was 19.9% diabetes and 41.7% prediabetes by OGTT.
- Using HbA1c alongside OGTT revealed higher prevalence: 28.0% diabetes and 60.4% prediabetes.
- HbA1c demonstrated superior diagnostic performance compared to FPG and 2hPG for detecting both diabetes and AGR.
Conclusions:
- A very high prevalence of undiagnosed AGR exists in patients undergoing CAG.
- HbA1c is a reliable and effective screening tool for AGR in this population.
- HbA1c can be considered an alternative to OGTT for AGR screening in patients undergoing CAG.
Background:
We aimed to investigate the prevalence of undiagnosed abnormal glucose regulation (AGR, including diabetes and prediabetes) in patients undergoing coronary angiography (CAG) by using both glycated hemoglobin (HbA1c) and oral glucose tolerance test (OGTT) to screen, and to compare the performance of fasting plasma glucose (FPG), 2-h plasma glucose (2hPG), and HbA1c for screening for AGR.
Methods:
Eligible patients were adults without known diabetes who were admitted for CAG. Patients' glucose regulation status was defined by conducting HbA1c and OGTT 2-4 weeks after hospital discharge. The performance of FPG, 2hPG, and HbA1c for detecting AGR was evaluated using receiver operating characteristic (ROC) analysis.
Results:
A total of 689 subjects were included. According to OGTT, the prevalence rates of diabetes and prediabetes were 19.9% and 41.7%, respectively. The corresponding values were 28.0% and 60.4%, respectively, when HbA1c was adopted as a diagnostic criterion in addition to OGTT. For detecting diabetes, the area under the ROC curve (AUC) was higher for HbA1c than for FPG (0.87 vs. 0.80, p=0.005), but was not significantly different from that for 2hPG (0.87 vs. 0.88, p=0.58). For detecting AGR, the AUC was higher for HbA1c than for either FPG (0.94 vs. 0.74, p<0.001) or 2hPG (0.94 vs. 0.83, p<0.001).
Conclusions:
Using HbA1c and OGTT to screen, we reported an extremely high prevalence of previously undiagnosed AGR (28.0% diabetes and 60.4% prediabetes) in patients admitted for CAG. HbA1c may be adopted as an alternative to OGTT for screening for AGR in patients undergoing CAG.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Hypoglycemia
Diabetes Mellitus: Type 2 and Gestational